Electromed (NYSE:ELMD) Downgraded by StockNews.com to Buy

StockNews.com downgraded shares of Electromed (NYSE:ELMD) from a strong-buy rating to a buy rating in a report released on Thursday morning.

Electromed Trading Up 2.7 %

Shares of NYSE:ELMD opened at $31.12 on Thursday. Electromed has a 12 month low of $9.90 and a 12 month high of $31.88. The company has a market capitalization of $263.28 million, a price-to-earnings ratio of 39.14 and a beta of 0.29. The firm’s 50-day moving average is $28.40 and its 200 day moving average is $21.41.

Electromed (NYSE:ELMD) last released its earnings results on Tuesday, November 12th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.13. The firm had revenue of $14.67 million for the quarter. Electromed had a return on equity of 15.32% and a net margin of 11.34%.

Insider Buying and Selling

In other Electromed news, Director Andrew Summers sold 12,731 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $29.98, for a total transaction of $381,675.38. Following the transaction, the director now directly owns 165,755 shares in the company, valued at $4,969,334.90. This trade represents a 7.13 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 14.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Electromed

Hedge funds and other institutional investors have recently made changes to their positions in the company. State Street Corp grew its holdings in Electromed by 14.5% during the 3rd quarter. State Street Corp now owns 22,066 shares of the company’s stock worth $474,000 after acquiring an additional 2,800 shares in the last quarter. Gabelli Funds LLC boosted its stake in shares of Electromed by 7.8% during the second quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock valued at $581,000 after purchasing an additional 2,808 shares in the last quarter. Pekin Hardy Strauss Inc. increased its holdings in Electromed by 9.9% during the third quarter. Pekin Hardy Strauss Inc. now owns 38,185 shares of the company’s stock valued at $820,000 after buying an additional 3,435 shares during the period. Renaissance Technologies LLC raised its stake in Electromed by 4.8% in the second quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock worth $1,548,000 after buying an additional 4,736 shares in the last quarter. Finally, Barclays PLC purchased a new stake in Electromed during the third quarter worth $215,000. Institutional investors own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.